Beijing, China

Chunxia Luo

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Chunxia Luo: Pioneering Chimeric Papilloma Virus Proteins

Introduction: Chunxia Luo is an esteemed inventor based in Beijing, China, who has made significant contributions to the field of biotechnology. Her remarkable work focuses on the development of chimeric papilloma virus L1 proteins, which holds promise for advancements in vaccine production and immunogenicity.

Latest Patents: Chunxia Luo holds a patent for a groundbreaking invention titled "Chimeric Papilloma Virus L1 Protein." This invention pertains to chimeric papilloma virus L1 proteins and the associated polynucleotides that encode them. The invention highlights the production of HPV virus-like particles, detailing methods of their preparation. The innovative chimeric papilloma virus L1 protein combines an N-terminal fragment from the L1 protein of one papilloma virus type and a C-terminal fragment from another. This combination not only maintains the immunogenicity of the respective HPV types but also enhances the expression levels and solubility, crucial for mass vaccine production.

Career Highlights: Chunxia Luo is currently associated with Sinocelltech Ltd., where she continues to delve into pioneering research. Her contributions have been vital in the intersection of molecular biology and vaccine technology, reflecting her commitment to improving public health through her innovations.

Collaborations: Throughout her career, Chunxia has collaborated with notable coworkers such as Liangzhi Xie and Wei Zhang. These partnerships foster an environment of collective innovation, allowing for enhanced research outcomes and the push towards developing effective biotechnological solutions.

Conclusion: Chunxia Luo exemplifies the spirit of innovation in the field of biotechnology with her significant contributions, particularly in the development of chimeric papilloma virus proteins. Her work at Sinocelltech Ltd. and collaborations with esteemed colleagues underscore her dedication to advancing the scientific community and improving global health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…